Resistance risk evaluation, "a European regulatory perspective"

被引:2
|
作者
Leonard, PK [1 ]
机构
[1] Cyanamid Int, B-5030 Gembloux, Belgium
关键词
D O I
10.1016/S0261-2194(00)00118-6
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
The European Union directive 91/414 on the inclusion of new and existing active substances requires an assessment of the potential risk of resistance being developed by target organisms and for management strategies to be introduced to address such risks. The European and Mediterranean Plant Protection Organisation (EPPO) worked with regulatory authorities and industry's Global Crop Protection Federation's (GCPF) Resistance Action Committees to develop a guideline that would satisfy these requirements. The new resistance risk analysis guideline was published in April 2000. Implementation of this guideline will force significant changes in the way crop protection products are developed. Applicants for registration of crop protection products will need to evaluate resistance risk and develop acceptable use patterns early in the development process. Registration applications for uses that are associated with an unacceptable resistance risk may be refused. In such cases, restriction or modification of supported use patterns to achieve acceptable levels of resistance risk, could result in use patterns which are no longer consistent with other elements of the registration dossier. It is therefore essential that resistance risk is evaluated early in development so that registration dossiers may be developed with this criteria in mind. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:905 / 909
页数:5
相关论文
共 50 条
  • [21] A European perspective on immunogenicity evaluation
    Schneider, Christian K.
    Papaluca, Marisa
    Kurki, Pekka
    NATURE BIOTECHNOLOGY, 2009, 27 (06) : 507 - 508
  • [22] Systemic Risk: Changing the Regulatory Perspective
    Rochet, Jean-Charles
    INTERNATIONAL JOURNAL OF CENTRAL BANKING, 2010, 6 (04): : 259 - 276
  • [23] ALLOCATING SYSTEMIC RISK IN A REGULATORY PERSPECTIVE
    Gourieroux, C.
    Monfort, A.
    INTERNATIONAL JOURNAL OF THEORETICAL AND APPLIED FINANCE, 2013, 16 (07)
  • [24] Risk and hazard: perspective of a regulatory agency
    Solecki, Roland
    TOXICOLOGY LETTERS, 2013, 221 : S57 - S58
  • [25] From Regulatory Knowledge to Regulatory Decisions: The European Evaluation of Medicines
    Boris Hauray
    Minerva, 2017, 55 : 187 - 208
  • [26] From Regulatory Knowledge to Regulatory Decisions: The European Evaluation of Medicines
    Hauray, Boris
    MINERVA, 2017, 55 (02) : 187 - 208
  • [27] Regulatory agencies, pharmaceutical information and the Internet: A European perspective
    Bauschke, Rafael
    HEALTH POLICY, 2012, 104 (01) : 12 - 18
  • [28] Regulatory aspects of drug dissolution from a European perspective
    Graffner, Christina
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 29 (3-4) : 288 - 293
  • [29] A European Regulatory Perspective towards a Euro 7 Proposal
    Samaras, Zissis C.
    Kontses, Anastasios
    Dimaratos, Athanasios
    Kontses, Dimitrios
    Balazs, Andreas
    Hausberger, Stefan
    Ntziachristos, Leonidas
    Andersson, Jon
    Ligterink, Norbert
    Aakko-Saksa, Paivi
    Dilara, Panagiota
    SAE International Journal of Advances and Current Practices in Mobility, 2022, 5 (03): : 998 - 1011
  • [30] European perspective on regulatory issues related to allergens.
    Bindslev-Jensen, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U83 - U83